{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:13:14Z","timestamp":1784650394518,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01462-4","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:47:28Z","timestamp":1759236448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural and hormonal changes in the ovaries of women with polycystic ovary syndrome and healthy controls: a 13-year prospective study in an unselected population"],"prefix":"10.1186","volume":"23","author":[{"given":"Nevda Ceren","family":"Sonu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren","family":"Aksun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Yarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent Okan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezcan","family":"Mumusoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"12","key":"1462_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355.","journal-title":"Hum Reprod"},{"issue":"1","key":"1462_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97(1):28\u2013e3825.","journal-title":"Fertil Steril"},{"issue":"2","key":"1462_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.fertnstert.2009.03.058","volume":"94","author":"BO Yildiz","year":"2010","unstructured":"Yildiz BO, Azziz R. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the androgen excess and PCOS society. Fertil Steril. 2010;94(2):690\u20133.","journal-title":"Fertil Steril"},{"key":"1462_CR4","unstructured":"Taylor HS, Pal L, Seli E, Fritz MA, editors. Speroff's Clinical Gynecologic Endocrinology and Infertility [PDF]. 9th ed. Philadelphia (PA): Wolters Kluwer; 2020. p. 982."},{"key":"1462_CR5","doi-asserted-by":"crossref","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et\u202fal. Recommendations from the 2023 International Evidence\u2011based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u20132469.","DOI":"10.1210\/clinem\/dgad463"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"key":"1462_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","volume":"12","author":"S Mumusoglu","year":"2020","unstructured":"Mumusoglu S, Yildiz BO. Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population. Curr Opin Endocr Metabolic Res. 2020;12:66\u201371.","journal-title":"Curr Opin Endocr Metabolic Res"},{"issue":"5","key":"1462_CR8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.fertnstert.2022.01.014","volume":"117","author":"J van Keizerswaard","year":"2022","unstructured":"van Keizerswaard J, Dietz de Loos ALP, Louwers YV, Laven JSE. Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study. Fertil Steril. 2022;117(5):1059\u201366.","journal-title":"Fertil Steril"},{"issue":"5","key":"1462_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/humrep\/den482","volume":"24","author":"M Hudecova","year":"2009","unstructured":"Hudecova M, Holte J, Olovsson M, Sundstr\u00f6m Poromaa I. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod. 2009;24(5):1176\u201383.","journal-title":"Hum Reprod"},{"issue":"5","key":"1462_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","volume":"96","author":"ZA Brown","year":"2011","unstructured":"Brown ZA, Louwers YV, Fong SL, Valkenburg O, Birnie E, de Jong FH, et al. The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril. 2011;96(5):1259\u201365.","journal-title":"Fertil Steril"},{"key":"1462_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.maturitas.2020.05.013","volume":"139","author":"N Helvaci","year":"2020","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome and aging: health implications after menopause. Maturitas. 2020;139:12\u20139.","journal-title":"Maturitas"},{"issue":"5","key":"1462_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40618-023-02230-0","volume":"47","author":"S Aksun","year":"2024","unstructured":"Aksun S, Sonu NC, Aygun S, Karakulak UN, Mumusoglu S, Yildiz BO. Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population. J Endocrinol Investig. 2024;47(5):1129\u201337.","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"1462_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF. Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2014;20(3):334\u201352.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"1462_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.fertnstert.2021.05.094","volume":"116","author":"A Dietz de Loos","year":"2021","unstructured":"Dietz de Loos A, Hund M, Buck K, Meun C, Sillman J, Laven JSE. Antim\u00fcllerian hormone to determine polycystic ovarian morphology. Fertil Steril. 2021;116(4):1149\u201357.","journal-title":"Fertil Steril"},{"issue":"6","key":"1462_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/ejendo\/lvad065","volume":"188","author":"TT Piltonen","year":"2023","unstructured":"Piltonen TT, Komsi E, Morin-Papunen LC, Korhonen E, Franks S, J\u00e4rvelin MR, et al. AMH as part of the diagnostic PCOS workup in large epidemiological studies. Eur J Endocrinol. 2023;188(6):547\u201354.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1462_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cen.13517","volume":"88","author":"T Sathyapalan","year":"2018","unstructured":"Sathyapalan T, Al-Qaissi A, Kilpatrick ES, Dargham SR, Atkin SL. Anti-M\u00fcllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018;88(2):258\u201362.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1462_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13224-017-1066-4","volume":"68","author":"U Saxena","year":"2018","unstructured":"Saxena U, Ramani M, Singh P. Role of AMH as diagnostic tool for polycystic ovarian syndrome. J Obstet Gynaecol India. 2018;68(2):117\u201322.","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"1462_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12958-021-00755-8","volume":"19","author":"F Ramezani Tehrani","year":"2021","unstructured":"Ramezani Tehrani F, Rahmati M, Mahboobifard F, Firouzi F, Hashemi N, Azizi F. Age-specific cut-off levels of anti-M\u00fcllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):76.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"1462_CR19","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98(8):3332\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1462_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","volume":"39","author":"G Bozdag","year":"2019","unstructured":"Bozdag G, Mumusoglu S, Coskun ZY, Yarali H, Yildiz BO. Anti-M\u00fcllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population. Reprod Biomed Online. 2019;39(3):522\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"1462_CR21","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"issue":"7","key":"1462_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/09513590.2017.1295440","volume":"33","author":"B Ozgen Saydam","year":"2017","unstructured":"Ozgen Saydam B, Has AC, Bozdag G, Oguz KK, Yildiz BO. Structural imaging of the brain reveals decreased total brain and total Gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts. Gynecol Endocrinol. 2017;33(7):519\u201323.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"1462_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/humrep\/dex226","volume":"32","author":"S Lie Fong","year":"2017","unstructured":"Lie Fong S, Laven JSE, Duhamel A, Dewailly D. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-M\u00fcllerian hormone using cluster analysis. Hum Reprod. 2017;32(8):1723\u201331.","journal-title":"Hum Reprod"},{"issue":"2","key":"1462_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.fertnstert.2011.11.041","volume":"97","author":"D Panidis","year":"2012","unstructured":"Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertil Steril. 2012;97(2):494\u2013500.","journal-title":"Fertil Steril"},{"issue":"4","key":"1462_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.fertnstert.2018.11.044","volume":"111","author":"AK Ahmad","year":"2019","unstructured":"Ahmad AK, Quinn M, Kao CN, Greenwood E, Cedars MI, Huddleston HG. Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria. Fertil Steril. 2019;111(4):787\u2013e932.","journal-title":"Fertil Steril"},{"issue":"7","key":"1462_CR26","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1210\/jc.2010-2959","volume":"96","author":"J Schmidt","year":"2011","unstructured":"Schmidt J, Br\u00e4nnstr\u00f6m M, Landin-Wilhelmsen K, Dahlgren E. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab. 2011;96(7):2178\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1462_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajog.2024.10.004","volume":"232","author":"M Barghi","year":"2025","unstructured":"Barghi M, Heidari Z, Haghighatdoost F, Feizi A, Hashemipour M. New insights into the relationship of antim\u00fcllerian hormone with polycystic ovary syndrome and its diagnostic accuracy: an updated and extended meta-analysis using a marginal beta-binomial model. Am J Obstet Gynecol. 2025;232(2):164\u2013e8731.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1462_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2024.05.163","volume":"122","author":"K van der Ham","year":"2024","unstructured":"van der Ham K, Laven JSE, Tay CT, Mousa A, Teede H, Louwers YV. Anti-m\u00fcllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. Fertil Steril. 2024;122(4):727\u201339.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01462-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:04:25Z","timestamp":1759280665000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01462-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01462-4","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Hacettepe University, Ankara, Turkey (Project number GO-21\/1201, Approval date:15.02.2022, Decision number: 2022\/03\u201306). The clinical examinations were conducted according to the ethical principles outlined in the Helsinki Declaration.Written informed consent was obtained from all participants before they participated in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}